These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 10235695)

  • 21. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
    Fava M; Dunner DL; Greist JH; Preskorn SH; Trivedi MH; Zajecka J; Cohen M
    J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of the clinical efficacy of mirtazapine.
    Benkert O; Muller M; Szegedi A
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S; Quercioli L; Bruscoli M
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mirtazapine versus other antidepressive agents for depression.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; Churchill R; Furukawa TA
    Cochrane Database Syst Rev; 2011 Dec; (12):CD006528. PubMed ID: 22161405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
    Montgomery SA; Reimitz PE; Zivkov M
    Int Clin Psychopharmacol; 1998 Mar; 13(2):63-73. PubMed ID: 9669186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mirtazapine augmentation in the treatment of refractory depression.
    Carpenter LL; Jocic Z; Hall JM; Rasmussen SA; Price LH
    J Clin Psychiatry; 1999 Jan; 60(1):45-9. PubMed ID: 10074878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression.
    Stahl S; Zivkov M; Reimitz PE; Panagides J; Hoff W
    Acta Psychiatr Scand Suppl; 1997; 391():22-30. PubMed ID: 9265948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirtazapine, an antidepressant.
    Puzantian T
    Am J Health Syst Pharm; 1998 Jan; 55(1):44-9. PubMed ID: 9437474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR; Nemeroff CB
    Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction.
    Koutouvidis N; Pratikakis M; Fotiadou A
    Int Clin Psychopharmacol; 1999 Jul; 14(4):253-5. PubMed ID: 10468319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    J Clin Psychiatry; 2008 Sep; 69(9):1404-15. PubMed ID: 19193341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does mirtazapine have a more rapid onset than SSRIs?
    Quitkin FM; Taylor BP; Kremer C
    J Clin Psychiatry; 2001 May; 62(5):358-61. PubMed ID: 11411818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of mirtazapine: a review.
    Montgomery SA
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():37-45. PubMed ID: 8930008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
    Brown MC; Nimmerrichter AA; Guest JF
    Eur Psychiatry; 1999 Jul; 14(4):230-44. PubMed ID: 10572352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.